Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol AHSG contributors: mct - updated : 15-12-2015
HGNC name alpha-2-HS-glycoprotein
HGNC id 349
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
7 - 1594 39.21 367 - -
EXPRESSION
Type restricted
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Cardiovascularheart    
Digestiveliver    
Lymphoid/Immunespleen    
Nervousbrainforebraincerebral cortex   Homo sapiensFetal
 brainlimbic systemhippocampus   Homo sapiensFetal
Reproductivefemale systembreastmammary gland  
Urinarykidneytubulecollecting duct   Homo sapiens
 kidneytubuleconvoluted tubule   Homo sapiens
cells
SystemCellPubmedSpeciesStageRna symbol
Digestivehepatocyte
Nervousependymal cell Homo sapiensFetal
Skeletonosteoblast Homo sapiens
cell lineage
cell lines
fluid/secretion serum
at STAGE
physiological period embryo
Text brain, bone marrow
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
conjugated GlycoP
isoforms Precursor
HOMOLOGY
intraspecies homolog to collagen
paralog to fetuin b
Homologene
FAMILY
  • fetuin family
  • CATEGORY regulatory , transport
    SUBCELLULAR LOCALIZATION extracellular
    intracellular,cytoplasm
    intracellular,nucleus
    text
  • FGF23 and AHSG proteins co-localized both in cytoplasm and nucleus, which suggests a possible reciprocal interactivity
  • basic FUNCTION
  • inhibitor of the insulin-receptor tyrosine kinase
  • involved in skeletal development and chronic disorder such as vascular calcifications
  • phosphate level is negatively correlated with AHSG level
  • implicated in the regulation of body fat and insulin sensitivity
  • negative acute phase protein involved in inflammatory diseases, thus being a potential physiological regulator of meprin (MEP1A, MEP1B) activity
  • CST3 an AHSG are endogenous inhibitors of human meprin metalloproteases
  • is a liver-derived blood protein that acts as a potent inhibitor of ectopic mineralization
  • fulfills likely the requirement of an endogenous ligand for TLR4 through which lipids induce insulin resistance
  • regulates potentially endochondral ossification through mineralization inhibition and lipid (hormone) binding
  • lipid-induced AHSG from adipocytes is an efficient chemokine for macrophage migration and polarization
  • acts as an inhibitor of systemic and local ectopic calcification and inflammatory response
  • mediator of inflammatory response that might also be involved in the pathogenesis of inflammatory bowel disease (IBD)
  • AHSG and/or palmitate influence the expression of proinflammatory and angiogenic proteins only partially via TLR4 signalling
  • contributes to the prevention of soft tissue calcification, modulates inflammation, reduces insulin sensitivity and fosters weight gain following high fat diet or ageing
  • liver-derived plasma protein with multiple functions, which is proteolytically processed to yield a disulfide-linked two-chain form
  • role in iron homeostasis
  • liver protein known to inhibit insulin actions
  • serum glycoprotein with recognized anti-calcification activity, also been suggested to modulate both bone formation and resorption
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS development , endocytosis transport
    text brain,bone mineralization
    PATHWAY
    metabolism
    signaling
    a component
  • two polypeptide chains cleaved from the precursor and linked by a disulfide bond
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • type II transmembrane serine protease controlling the expression of hepcidin, the key regulator of iron homeostasis
  • testosterone participates in the regulation of hepatic AHSG expression, an effect mediated, at least partially, by androgen receptor activation
  • substrate of TMPRSS6
  • AHSG is produced in bone, mainly in osteocytes, and its production is modulated by FGF23
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional     --low  
    is correlated with the development of cardiovascular diseases (CVD)
    constitutional     --low  
    decreased serum AHSG levels were independently associated with disease activity in patients with Crohn disease and ulcerative colitis
    constitutional     --low  
    in patients with Alzheimer, disease in proportion to the severity of cognitive impairment
    constitutional     --low  
    nephrolithiasis patients had lower AHSG protein level in urine and renal tissue
    constitutional     --low  
    AHSG, MMP9, and MMP3 levels were significantly lower in migraine than controls
    constitutional     --over  
    in diabetes patients with nonalcoholic fatty liver disease (NAFLD)
    constitutional     --low  
    serum AHSG concentration is decreased and reflects-at least partly-systemic inflammation in preeclampsia
    Susceptibility to low body mass index
    Variant & Polymorphism SNP
  • SNP associated to low body mass index
  • variant Thr230Met associated with a marked increase in beta2-adrenoceptor sensitivity in subcutaneous fat cells, which may be of importance in body weight regulation
  • Candidate gene
    Marker
  • may serve as a biological link between vascular disease and normal age-related cognitive decline
  • biomarker reported to be important in many metabolic disorders, including obesity, diabetes, and hepatic steatosis
  • Therapy target
    ANIMAL & CELL MODELS
  • Fetuin-A deficiency in mice resulted in decreased hepcidin mRNA levels